Pharmacosmos Therapeutics is a U.S. specialty pharmaceutical company focused on IV iron treatment of Iron Deficiency Anemia. Our goal is to support patients and healthcare professionals with a range of iron therapies, tools and resources.
We are a wholly owned subsidiary of Pharmacosmos, a Holbaek, Denmark-based pharmaceutical company that develops, manufactures, and markets medicines for the treatment of iron deficiency anemia in humans and animals, as well as advanced carbohydrates for pharmaceutical and technical uses. In addition to the U.S., Pharmacosmos has affiliates in the UK, Ireland, China, Germany and in the Nordics.
At Pharmacosmos, we are specialists in iron therapy. We develop, manufacture and market medicines for the treatment of iron deficiency anemia in humans and animals. We inform patients and health care personnel about iron deficiency anemia and related conditions and provide education and information regarding approved treatments for those conditions for appropriate patients. We are furthermore specialists in developing and producing advanced carbohydrates for pharmaceutical and technical uses.